Dayle Anne Callaghan
51 - 200 employees
We have observed 44 EP applications Dayle Anne Callaghan has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
COMPOSITIONS AND METHODS FOR LEACH EXTRACTION OF MICROORGANISMS
- IPC classification:
- C12P 7/00
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Agent:
- William Gerrit Arends, Marks & Clerk
- Status:
- █ EXAMINATION REQUESTED
ROBOTIC SURGICAL DEVICES, SYSTEMS AND RELATED METHODS
- IPC classification:
- G05B 19/00, G05B 15/00
- Applicant:
- University of Nebraska
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
METHOD OF EXTRACTING LUTEIN/XANTHOPHYLLS FROM NATURAL MATERIALS AND HIGHLY PURIFIED LUTEIN/XANTHOPHYLLS OBTAINED FROM THE METHOD THEREOF
- IPC classification:
- C07C 403/24
- Applicant:
- Chulalongkorn University
- Agent:
- Cabinet Plasseraud
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ The patent has been granted
FUS1/TUSC2 THERAPIES
- IPC classification:
- A61K 48/00, G01N 33/00
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ PATENT GRANTED
SELF-LAUNCHING MOVABLE SCAFFOLDING SYSTEM
- IPC classification:
- E01D 21/00
- Agent:
- Cabinet Plasseraud
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
Improved neurturin molecules
- IPC classification:
- A61K 38/17, C07K 14/475, C07K 14/47, A61P 25/00
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ The patent has been granted
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
- IPC classification:
- A61K 47/44, A61K 47/14, A61K 47/12, A61K 31/568, A61K 9/48, A61K 9/107
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ The patent has been granted
SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM
- IPC classification:
- C12P 21/02, C12N 15/79, C12N 15/74, C12N 15/70, C12N 1/20
- Applicant:
- University of Arkansas
- Applicant:
- University of Pittsburgh of the Commonwealth System of Higher Education
- Agent:
- Multiple attorneys, Kilburn & Strode LLP
- Agent:
- Marks & Clerk
- Agent:
- Multiple attorneys, Rouse IP Limited
- Status:
- █ EXAMINATION IN PROGRESS
SYSTEMS AND METHODS TO DETERMINE AND MONITOR CHANGES IN RAIL CONDITIONS
- IPC classification:
- G01N 29/00
- Applicant:
- University of Nebraska
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
HIGH THROUGHPUT SEQUENCING OF MULTIPLE TRANSCRIPTS OF A SINGLE CELL
- IPC classification:
- C12Q 1/68
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
LOCAL CONTROL ROBOTIC SURGICAL DEVICES AND RELATED METHODS
- IPC classification:
- B25J 17/02, B25J 9/18, B25J 9/04
- Applicant:
- University of Nebraska
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ PATENT GRANTED
APPARATUS FOR CONVERTING ENERGY FROM FLUID FLOW
- IPC classification:
- F03B 13/08
- Agent:
- Multiple attorneys, Kilburn & Strode LLP
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ The patent has been granted
METHODS, SYSTEMS, AND DEVICES RELATING TO OPEN MICROFLUIDIC CHANNELS
- IPC classification:
- B81C 1/00, B81B 1/00
- Agent:
- Appleyard Lees Ltd
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ The patent has been granted
DIRECTIONAL ELUTING IMPLANTABLE MEDICAL DEVICE
- IPC classification:
- A61F 2/90, A61F 2/86, A61F 2/82
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ APPLICATION DEEMED TO BE WITHDRAWN
ASCORBIC ACID-ELUTING IMPLANTABLE MEDICAL DEVICES, SYSTEMS, AND RELATED METHODS
- IPC classification:
- A61F 2/02
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
ROBOTIC SURGICAL DEVICES, SYSTEMS, AND RELATED METHODS
- IPC classification:
- A61B 1/313
- Applicant:
- University of Nebraska
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- David Michael Grant, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
A NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS
- IPC classification:
- A61K 39/385, A61K 39/08, G01N 33/569, C12N 15/31, C07K 19/00, C07K 16/12, C07K 14/33, A61P 37/04, A61P 31/04
- Applicant:
- University of Guelph
- Agent:
- William Gerrit Arends, Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
GOLD RECOVERY FROM REFRACTORY ORES AND CONCENTRATES
- IPC classification:
- C22B 11/00, C22B 3/00
- Agent:
- Boult Wade Tennant Ltd
- Agent:
- Marks & Clerk
- Agent:
- Dayle Anne Callaghan, Rouse IP Limited
- Status:
- █ GRANT OF PATENT INTENDED
ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF
- IPC classification:
- A61P 25/00, A61K 39/395, C07K 16/44
- Applicant:
- United Arab Emirates University
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Agent:
- David Michael Grant, Marks & Clerk
- Status:
- █ EXAMINATION REQUESTED
SOFT TISSUE IMPLANT
- IPC classification:
- C12N 5/071, A61K 35/52, A01N 63/00
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ GRANT OF PATENT INTENDED
APPARATUS FOR HANGING DROP DETECTION OF EPIDURAL SPACE PENETRATION
- IPC classification:
- A61M 5/00
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ GRANT OF PATENT INTENDED
VESICLES
- IPC classification:
- A61K 8/67, A61K 8/14, A61Q 19/08, A61Q 17/04, A61K 8/55, A61K 8/06, A61K 8/02, A61K 9/107, A61K 9/127, A61K 9/00, A61K 47/24, A61K 47/48
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ GRANT OF PATENT INTENDED
E. COLI SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM
- IPC classification:
- C12P 21/02, C12N 15/79, C12N 15/74, C12N 15/70, C12N 1/20
- Applicant:
- University of Arkansas
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ GRANT OF PATENT INTENDED
MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF
- IPC classification:
- A61K 39/00, C12N 5/07, C12P 21/06, C12P 21/08
- Applicant:
- Zymeworks Inc
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
USE OF FLUORINATED CYCLIC DINUCLEOTIDES AS ORAL VACCINE ADJUVANTS
- IPC classification:
- A61P 37/04, A61P 31/04, A61K 31/7084, A61K 39/39
- Applicant:
- Brock University
- Applicant:
- National Research Council of Canada
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
FORMULATIONS FOR LYSOSOMAL ENZYMES
- IPC classification:
- A61P 3/00, A61K 38/46, A61K 47/30, A61K 47/34, A61K 38/17, A61K 38/16
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
- IPC classification:
- A61K 35/00, A61K 35/745, A61K 35/744, A61K 35/742
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION IN PROGRESS
BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2
- IPC classification:
- C40B 40/08, C12N 5/10, C12N 15/13, C07K 16/28, A61P 35/00, A61K 47/48, A61K 39/395, C07K 16/46
- Applicant:
- Zymeworks Inc
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE
- IPC classification:
- A61P 35/00, A61K 31/337, A61K 31/496
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
NOVEL FULL SPECTRUM ANTI-DENGUE ANTIBODY
- IPC classification:
- C07K 16/00, C12P 21/08, A61K 39/42, A61K 39/395
- Applicant:
- Massachusetts Institute of Technology (MIT) Inc.
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
CARBOXY-CYCLOPROPYL UNDECANOL COMPOUNDS FOR TREATMENT OF LIVER DISEASE AND OTHER MEDICAL DISORDERS
- IPC classification:
- A61P 31/18, A61P 31/12, A61P 1/16, A61K 31/194
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
TURBINE ASSEMBLY
- IPC classification:
- F03B 17/06, F03B 13/08
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
COMPOSITIONS FOR INFUSION OF TRANSIENTLY ENGRAFTING, SELECTED POPULATIONS OF ALLOGENEIC LYMPHOCYTES
- IPC classification:
- C12N 5/078, A61P 35/00, A61P 7/00, A61K 38/00
- Applicant:
- Johns Hopkins University
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ The patent has been granted
DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE
- IPC classification:
- A61P 31/04, A61K 38/48, C12N 9/52
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
MODIFIED LATENCY ASSOCIATED PROTEIN CONSTRUCT
- IPC classification:
- C12N 15/62, C07K 14/495
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ EXAMINATION REQUESTED
COMPOUNDS FOR USE AS IMAGING AGENTS
- IPC classification:
- A61P 25/28, A61K 31/343, A61K 31/352, A61K 31/704, G01N 33/58
- Applicant:
- United Arab Emirates University
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
RVG DERIVED PEPTIDES
- IPC classification:
- A61P 25/28, A61K 47/50, A61K 47/42, C07K 7/06, C07K 14/145
- Applicant:
- United Arab Emirates University
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS
- IPC classification:
- A61P 35/00, A61K 39/395, A61K 31/496
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
ADOPTIVE CELL TRANSFER METHODS
- IPC classification:
- A61K 31/727
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION
- IPC classification:
- A61K 31/727
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION
- IPC classification:
- A61P 35/00, A61K 31/496
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
METHOD OF TREATING A BRAIN TUMOR
- IPC classification:
- A61P 35/00, A61K 31/496
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
PLINABULIN COMPOSITIONS
- IPC classification:
- C07D 403/06
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES
- IPC classification:
- G01N 33/50, G01N 33/48, G01N 33/68, A61P 25/28
- Agent:
- Dayle Anne Callaghan, Kilburn & Strode LLP
- Status:
- █ Request for examination was made